ACTIVE

ENDOCEUTICS

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

119,5 k €

+1174.6% YoY

Gross margin

123,2 k €

+859.3% YoY

Equity

-114,1 k €

+51.2% YoY

What does ENDOCEUTICS do?

ENDOCEUTICS is a Public limited company incorporated in 2018. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0715.565.040

Incorporation

06/12/2018

Legal form

Public limited company

Registered office

Rue Belliard 40
1040 Bruxelles · BruxellesSee on map

Contributed capital

61 500,00 €

Latest accounts

31/12/2024

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods

Signals

ProfitablePositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 6 financial years

	2024		2023		2022		2021		2020		2019
Income statement
Gross margin	123,2 k €	+859%	12,8 k €	-91.4%	148,7 k €	+476%	-39,5 k €	-214%	34,8 k €	+108%	-450,7 k €
EBITDA	123,2 k €	+900%	12,3 k €	-91.7%	147,8 k €	+460%	-41,1 k €	-219%	34,4 k €	+108%	-451,8 k €
Operating result	123,2 k €	+900%	12,3 k €	-91.7%	147,8 k €	+460%	-41,1 k €	-219%	34,4 k €	+108%	-451,8 k €
Net result	119,5 k €	+1175%	9,4 k €	-93.7%	148 k €	+530%	-34,4 k €	-201%	34,1 k €	+108%	-452,2 k €
Balance sheet
Equity	-114,1 k €	+51.2%	-233,6 k €	+3.9%	-243 k €	+37.9%	-391 k €	-9.6%	-356,6 k €	+8.7%	-390,7 k €
Total assets	4,7 M €	+353%	1 M €	+61.9%	641,4 k €	-10.7%	718,2 k €	-63.9%	2 M €	-12.3%	2,3 M €
Cash	421,5 k €	+715%	51,7 k €	-79.8%	256,5 k €	-27.5%	353,7 k €	-76.2%	1,5 M €	+975%	138,5 k €
Debts	4,8 M €	+279%	1,3 M €	+43.9%	884,3 k €	-20.3%	1,1 M €	-52.8%	2,3 M €	-10.9%	2,6 M €

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 4 active · 2 ended

Active mandates

MYRIEL PHARMACEUTICAL LLC

Director · since 23 mai 2023

Represented by SERGE ILIN-SCHNEIDER

Active

MYRIEL PHARMACEUTICALS ULC

Director · since 23 mai 2023

Represented by APURVA OM SARAF

Active

Endoceutics Inc

Director · since 06 décembre 2018 · until 23 mai 2023

Represented by Claude Labrie

Active

Endoceutics Pharma (USA) Inc

Director · since 06 décembre 2018 · until 23 mai 2023

Represented by Turpin Dennis

Active

Ended mandates

Endoceutics Inc

Director · since 06 décembre 2018

Represented by Claude Labrie

Ended

Endoceutics Pharma (USA) Inc

Director · since 06 décembre 2018

Represented by Turpin Dennis

Ended

At this address

Other companies at this address

Company	CBE no.
AECC● Active	0541.243.964
AED GVBF 1● Active	1003.556.060
AED GVBF 10● Active	1003.554.971
AED GVBF 2● Active	1003.556.654
AED GVBF 3● Active	1003.557.347
AED GVBF 4● Active	1003.557.644
AED GVBF 5● Active	1003.552.201
AED GVBF 6● Active	1003.553.090
AED GVBF 7● Active	1003.553.684
AED GVBF 8● Active	1003.554.377
AED GVBF 9● Active	1003.554.674
AEDIFICA● Active	0877.248.501
AEDIFICA INVEST● Active	0879.109.317
Agricultural Crops Licensing Platform● Active	0800.817.746
AI, Data and Robotics Association● Active	0768.619.684
Airlines International Representation in Europe● Active	0424.052.821
Ambassade du Commonwealth des Bahamas● Active	0725.846.941
ASD-STAN● Active	0866.465.960
A.SPIRE● Active	0848.414.953
ASSOCIATION EUROPEENNE DU CHARBON ET DU LIGNITE● Active	0408.290.816

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	06/12/2018
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	13 months
Filing date	14/08/2025	18/07/2024	02/05/2023	08/08/2022	29/07/2021	25/06/2020
General meeting	17/07/2025	28/06/2024	24/04/2023	30/06/2022	30/06/2021	19/06/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

6 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	17/07/2025	14/08/2025	French	PDF
Abridged model	31/12/2023	28/06/2024	18/07/2024	French	PDF
Abridged model	31/12/2022	24/04/2023	02/05/2023	French	PDF
Abridged model	31/12/2021	30/06/2022	08/08/2022	French	PDF
Abridged model	31/12/2020	30/06/2021	29/07/2021	French	PDF
Abridged model	31/12/2019	19/06/2020	25/06/2020	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 4 active · 2 ended

Active mandates

MYRIEL PHARMACEUTICAL LLC

Director · since 23 mai 2023

Represented by SERGE ILIN-SCHNEIDER

Active

MYRIEL PHARMACEUTICALS ULC

Director · since 23 mai 2023

Represented by APURVA OM SARAF

Active

Endoceutics Inc

Director · since 06 décembre 2018 · until 23 mai 2023

Represented by Claude Labrie

Active

Endoceutics Pharma (USA) Inc

Director · since 06 décembre 2018 · until 23 mai 2023

Represented by Turpin Dennis

Active

Ended mandates

Endoceutics Inc

Director · since 06 décembre 2018

Represented by Claude Labrie

Ended

Endoceutics Pharma (USA) Inc

Director · since 06 décembre 2018

Represented by Turpin Dennis

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates22/02/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates01/02/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
PDF
Mandates22/07/2019
DEMISSIONS, NOMINATIONS
PDF
Mandates21/03/2019
DEMISSIONS, NOMINATIONS
PDF
Other10/12/2018
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024119,5 k €↑
2023
Annual accounts 20239,4 k €↓
2022
Annual accounts 2022148 k €↑
2021
Annual accounts 2021-34,4 k €↓
2020
Annual accounts 202034,1 k €↑
2019
Annual accounts 2019-452,2 k €
06/12/2018
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ENDOCEUTICS

Overview

What does ENDOCEUTICS do?

Trend over 6 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline